Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation
Value in Health - United Kingdom
doi 10.1016/j.jval.2019.09.2747
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Elsevier BV